Cleton FJ - Search Results

1

[Immunotherapy of cancer with interleukin-2 and with interleukin-2 activated cells].

Osanto S, Brand A, van Rood JJ, Cleton FJ. Osanto S, et al. Among authors: cleton fj. Ned Tijdschr Geneeskd. 1989 Jul 15;133(28):1392-5. Ned Tijdschr Geneeskd. 1989. PMID: 2677758 Review. Dutch. No abstract available.

2

Hypothyroidism during immunotherapy with interleukin-2 is associated with antithyroid antibodies and response to treatment.

Weijl NI, Van der Harst D, Brand A, Kooy Y, Van Luxemburg S, Schroder J, Lentjes E, Van Rood JJ, Cleton FJ, Osanto S. Weijl NI, et al. Among authors: cleton fj. J Clin Oncol. 1993 Jul;11(7):1376-83. doi: 10.1200/JCO.1993.11.7.1376. J Clin Oncol. 1993. PMID: 8315436 Clinical Trial.

3

[Scintigraphic studies in the detection of cancer using anti-tumor monoclonal antibodies].

Pauwels EK, Cleton FJ, Osanto S. Pauwels EK, et al. Among authors: cleton fj. Ned Tijdschr Geneeskd. 1984 Apr 28;128(17):805-9. Ned Tijdschr Geneeskd. 1984. PMID: 6717657 Dutch. No abstract available.

4

Myocardial injury after interleukin-2 therapy.

Osanto S, Cluitmans FH, Franks CR, Bosker HA, Cleton FJ. Osanto S, et al. Among authors: cleton fj. Lancet. 1988 Jul 2;2(8601):48-9. doi: 10.1016/s0140-6736(88)92982-0. Lancet. 1988. PMID: 2898655 No abstract available.

5

Free radicals and antioxidants in chemotherapy-induced toxicity.

Weijl NI, Cleton FJ, Osanto S. Weijl NI, et al. Among authors: cleton fj. Cancer Treat Rev. 1997 Jul;23(4):209-40. doi: 10.1016/s0305-7372(97)90012-8. Cancer Treat Rev. 1997. PMID: 9377594 Review. No abstract available.

6

In vivo effects of combination treatment with recombinant interferon-gamma and -alpha in metastatic melanoma.

Osanto S, Jansen R, Naipal AM, Gratama JW, van Leeuwen A, Cleton FJ. Osanto S, et al. Among authors: cleton fj. Int J Cancer. 1989 Jun 15;43(6):1001-6. doi: 10.1002/ijc.2910430608. Int J Cancer. 1989. PMID: 2499552 Clinical Trial.

7

HL-A antigens and breast cancer.

de Jong-Bakker M, Cleton FJ, D'Amaro J, Keuning JJ, Van Rood JJ. de Jong-Bakker M, et al. Among authors: cleton fj. Eur J Cancer (1965). 1974 Sep;10(9):555-8. doi: 10.1016/0014-2964(74)90041-3. Eur J Cancer (1965). 1974. PMID: 4461283 No abstract available.

8

Cisplatin combination chemotherapy induces a fall in plasma antioxidants of cancer patients.

Weijl NI, Hopman GD, Wipkink-Bakker A, Lentjes EG, Berger HM, Cleton FJ, Osanto S. Weijl NI, et al. Among authors: cleton fj. Ann Oncol. 1998 Dec;9(12):1331-7. doi: 10.1023/a:1008407014084. Ann Oncol. 1998. PMID: 9932164 Free article. Clinical Trial.

9

Vaccination of melanoma patients with an allogeneic, genetically modified interleukin 2-producing melanoma cell line.

Osanto S, Schiphorst PP, Weijl NI, Dijkstra N, Van Wees A, Brouwenstein N, Vaessen N, Van Krieken JH, Hermans J, Cleton FJ, Schrier PI. Osanto S, et al. Among authors: cleton fj. Hum Gene Ther. 2000 Mar 20;11(5):739-50. doi: 10.1089/10430340050015635. Hum Gene Ther. 2000. PMID: 10757353 Clinical Trial.

10

Plasmapheresis treatment of haemorrhagic complications in a patient with multiple myeloma.

Tan BL, Cleton FJ, van Beusekom GT, Veltkamp JJ, van Rood JJ. Tan BL, et al. Among authors: cleton fj. Folia Med Neerl. 1967;10(6):174-9. Folia Med Neerl. 1967. PMID: 5590976 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

86 results

Search Page

Filters